Huawei’s AI chip sales surge as Nvidia stalls in China - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Huawei’s AI chip sales surge as Nvidia stalls in China

Chinese tech companies place large orders for the Shenzhen-based group’s latest range of AI processors
00:00

{"text":[[{"start":7.35,"text":"Huawei is set to capture the largest share of China’s AI chip market this year, with sales jumping by at least 60 per cent amid strong demand from Chinese companies seeking domestic alternatives to Nvidia."}],[{"start":20.2,"text":"China’s tech groups have placed large orders for Huawei’s latest Ascend processor 950PR, according to two people with knowledge of the matter, as the Shenzhen-based company races to make inroads into a sector long dominated by the $5.1tn US chip group."}],[{"start":37.45,"text":"Huawei expects revenues from its AI chips to reach about $12bn this year based on orders it has already received, up from $7.5bn in 2025. The majority of orders this year are for 950PR, which entered mass production in March. It also plans to launch an upgraded version of 950DT in the fourth quarter, the people said."}],[{"start":62,"text":"The Chinese tech group has aggressively expanded its chipmaking capabilities as Nvidia continues to face regulatory barriers in Washington and Beijing."}],[{"start":70.85,"text":"While Nvidia chief Jensen Huang said in March the company had finally received US licences to sell its H200 chips to China, no shipments have yet been made due to regulatory issues, according to two people with knowledge of the matter."}],[{"start":null,"text":"

Jensen Huang applauds while wearing a black leather jacket on stage at the Nvidia GTC conference.
"}],[{"start":86.55,"text":"Beijing has told Chinese tech companies to support domestic producers and limit their use of Nvidia chips to overseas, one of the people said. Meanwhile US regulators require that all Nvidia chips ordered by Chinese clients only be used in China, according to the person. This has led to no customs clearance for H200 in China, which is required for shipments."}],[{"start":108.9,"text":"Huawei’s AI chip revenue forecast could rise if its production ramp-up exceeds projections, the people said."}],[{"start":116.25,"text":"The Chinese tech group manufactures most of its AI chips with Semiconductor Manufacturing International Corporation (SMIC), China’s leading fab. Later this year two additional fabrication plants dedicated to its needs are scheduled to launch."}],[{"start":129.85,"text":"While Huawei’s latest chips still lag Nvidia’s most advanced products by at least two generations, the Chinese company has steadily improved the performance and efficiency of its AI chips. "}],[{"start":141.95,"text":"The Chinese tech group has positioned its latest 950PR processors as the hardware of choice for domestic companies running “inference”, the computation LLMs use to generate responses. "}],[{"start":155.6,"text":"Huawei is betting that inference, which is technically less challenging than model training, will be a bigger future source of demand as AI applications such as agents become more widespread."}],[{"start":167.29999999999998,"text":"The tech group is also leveraging its networking capability to build powerful computing clusters, offsetting weaker single-chip performance."}],[{"start":null,"text":"
A gloved hand uses a tool to remove a Kirin 9000s chip from a Huawei Mate X5 smartphone circuit board.
"}],[{"start":175.35,"text":"Earlier this month DeepSeek said it worked with Huawei’s 950PR for its latest V4 model, which features improved inference efficiency at reduced costs. But the majority of V4’s training was still done on Nvidia’s chips, according to people familiar with the matter. "}],[{"start":191.29999999999998,"text":"“The day that DeepSeek comes out on Huawei first, that is a horrible outcome for our nation,” Nvidia’s Huang said in a recent interview with podcaster Dwarkesh Patel. It could lead to a scenario where “AI models around the world are developed and they run best on non-American hardware”, he added. "}],[{"start":210.2,"text":"A key challenge for Nvidia’s Chinese competitors has been building a software system to rival the US chipmaker’s Cuda, which remains dominant globally. "}],[{"start":220.39999999999998,"text":"Huawei’s Cann, started a decade after Cuda, has drawn complaints for being difficult to use, which greatly increases clients’ operating costs. While improvements are being made, its disadvantage compared to Nvidia’s Cuda remains significant, developers say. "}],[{"start":237.39999999999998,"text":"Morgan Stanley forecasts China’s AI chip market will reach $67bn in 2030, with 86 per cent expected to be supplied by Chinese players. It estimates the market to be about $21bn this year from domestic suppliers. "}],[{"start":252.79999999999998,"text":"China’s AI chip sector was previously dominated by Nvidia, which sold $17.1bn in fiscal year 2025, mostly from H20, a watered-down product tailored for China to meet US export controls."}],[{"start":267.7,"text":"Since the US banned the sales of the H20 to China a year ago, Nvidia has struggled to re-enter the market with another AI chip that would satisfy both US and Chinese regulators’ concerns."}],[{"start":279.75,"text":"“Two structural forces shape the market: a rapid rise in AI inference demand . . . and persistent export controls, making localization a long-duration feature of China’s AI compute market rather than a temporary policy response,” wrote Morgan Stanley analysts. "}],[{"start":297.25,"text":"Huawei did not respond to a request for comment. Nvidia declined to comment."}],[{"start":302.3,"text":"With additional reporting from Cheng Leng in Beijing and Demetri Sevastopulo in Washington"}],[{"start":314.8,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1777599931_5645.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
2天前

法国将迎来最拥挤的大选角逐场:谁将取代马克龙?

左翼和中间阵营的分裂,助长了极右翼问鼎爱丽舍宫的希望。
设置字号×
最小
较小
默认
较大
最大
分享×